Clinical trial

DreaMS - Validation Study 1

NCT05009160

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2022-03-30

PhaseN/A

Study timeline

Study start (actual)2022-03-30Date precision: day

Registry last updated2026-03-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisverified · MONDO: multiple sclerosis

Interventions

dreaMS App R2.1DEVICE

Sponsors & collaborators

Research Center for Clinical Neuroimmunology and Neuroscience Basellead sponsor

University Hospital, Basel, Switzerlandcollaborator

University of Baselcollaborator

Innosuisse - Swiss Innovation Agencycollaborator

Novartis Pharmaceuticalscollaborator

Hoffmann-La Rochecollaborator

Indivi AGcollaborator

Mapped research locations

BaselSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05009160 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.